1. BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL. (12th June 2019) Authors: Trněný, M.; Canales Ruiz, I.; Martelli, M.; Sehn, L.H.; Vitolo, U.; Brown, H.; Nielsen, T.; Sellam, G.; Kostakoglu, L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA. (June 2017) Authors: Chiappella, A.; Agostinelli, C.; Martelli, M.; Evangelista, A.; Fabbri, M.; Melle, F.; Motta, G.; Righi, S.; Novero, D.; Balzarotti, M.; Cabras, M.G.; Carella, A.M.; Gotti, M.; Pavone, V.; Tucci, A.; Ladetto, M.; Gaidano, G.; Vitolo, U.; Pileri, S.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. (June 2017) Authors: Fowler, N.; Gopal, A.K.; Schuster, S.J.; Trotman, J.; Hess, G.; Hou, J.; Yacoub, A.; Lill, M.; Martin, P.; Vitolo, U.; Spencer, A.; Radford, J.; Jurczak, W.; Morton, J.; Osmanov, D.; Caballero, D.; Deshpande, S.; Vermeulen, J.; Damle, R.; Schaffer, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY. (June 2017) Authors: Klanova, M.; Sehn, L.H.; Bence‐Bruckler, I.; Cavallo, F.; Jin, J.; Martelli, M.; Stewart, D.; Vitolo, U.; Zaja, F.; Zhang, Q.; Mattiello, F.; Oestergaard, M.Z.; Fingerle‐Rowson, G.R.; Nielsen, T.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE. (June 2017) Authors: Fornecker, L.; Ou, F.; Dixon, J.G.; Casulo, C.; Hoster, E.; Hiddemann, W.; Sebban, C.; Morschhauser, F.; Marcus, R.; Hochster, H.; Rummel, M.; Hagenbeeck, A.; Kimby, E.; Herold, M.; Peterson, B.A.; Gyan, E.; Ladetto, M.; Zucca, E.; Nielsen, T.; Foon, K. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM‐PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET‐ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL). (June 2017) Authors: Rigacci, L.; Puccini, B.; Zinzani, P.; Kovalchuk, S.; Broccoli, A.; Evangelista, A.; Gioia, D.; Mannelli, L.; Castagnoli, A.; Santoro, A.; Bonfichi, M.; Rossi, G.; Anastasia, A.; Zaja, F.; Vitolo, U.; Pavone, V.; Pulsoni, A.; Gaidano, G.; Stelitano, C.; Salvi, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. END OF TREATMENT PET‐CT PREDICTS PROGRESSION‐FREE SURVIVAL IN DLBCL AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY. (June 2017) Authors: Kostakoglu, L.; Martelli, M.; Belada, D.; Carella, A.M.; Chua, N.; Gonzalez‐Barca, E.; Hong, X.; Pinto, A.; Sehn, L.H.; Shi, Y.; Tatsumi, Y.; Fingerle‐Rowson, G.; Mattiello, F.; Nielsen, T.; Sahin, D.; Vitolo, U.; Trněný, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS. (12th June 2019) Authors: Stefoni, V.; Broccoli, A.; Botto, B.; Corradini, P.; Pinto, A.; Re, A.; Vitolo, U.; Fanti, S.; Argnani, L.; Zinzani, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HBV reactivation in pOBI is influenced by detectable viremia at baseline rather than duration of prophylaxis with lamivudine. Issue 1 (16th February 2017) Authors: Cavallo, F.; Ghione, P.; Battaglini, M.; Botto, B.; Caracciolo, D.; Ferrero, S.; Passera, R.; Vitolo, U.; Boccadoro, M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Rusconi, C.; Tucker, D.; Bernard, S.; Muzi, C.; Crucitti, L.; Stefani, P.; Cox, M.; Gini, G.; Re, A.; Sciarra, R.; Liberati, A.; Morello, L.; Arcari, A.; Mannina, D.; Vitagliano, O.; Sartori, R.; Chiappella, A.; Balzarotti, M.; Vitolo, U.; Thieblemont, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗